UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss

Pharmacological research, 2014-06, Vol.84, p.1-11

2014

Volltextzugriff (PDF)

Effect of time restricted eating on body weight and fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trial

Nutrition & diabetes, 2021-01, Vol.11 (1), p.6-6, Article 6

2021

Volltextzugriff (PDF)

Stress-associated weight gain, fibromyalgia symptoms, cardiometabolic markers, and human growth hormone suppression respond to an amino acid supplement blend: Results of a prospective, cohort study

Frontiers in endocrinology (Lausanne), 2023-03, Vol.14, p.1053692-1053692

2023

Volltextzugriff (PDF)

Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer

Prostate cancer and prostatic diseases, 2023-12

2023

Volltextzugriff (PDF)

Diet-Induced Obesity Causes Severe but Reversible Leptin Resistance in Arcuate Melanocortin Neurons

Cell metabolism, 2007-03, Vol.5 (3), p.181-194

2007

Volltextzugriff (PDF)

Catecholamine Reuptake Inhibition Causes Weight Loss by Increasing Locomotor Activity and Thermogenesis

Neuropsychopharmacology (New York, N.Y.), 2008-05, Vol.33 (6), p.1287-1297

2008

Volltextzugriff (PDF)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer

Frontiers in oncology, 2023-04, Vol.13, p.1134763-1134763

2023

Volltextzugriff (PDF)

Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism

Molecular metabolism (Germany), 2012-12, Vol.1 (1), p.86-93

2012

Volltextzugriff (PDF)

Combination therapy with naltrexone and bupropion for obesity

Expert opinion on pharmacotherapy, 2011-08, Vol.12 (11), p.1813-1826

2011

Volltextzugriff (PDF)

Inhibition of Dopamine and Norepinephrine Reuptake Produces Additive Effects on Energy Balance in Lean and Obese Mice

Neuropsychopharmacology (New York, N.Y.), 2007-04, Vol.32 (4), p.822-834

2007

Volltextzugriff (PDF)

Peptide YY(3–36) Inhibits Morning, but Not Evening, Food Intake and Decreases Body Weight in Rhesus Macaques

Diabetes (New York, N.Y.), 2005-11, Vol.54 (11), p.3198-3204

2005

Volltextzugriff (PDF)

An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects

Addictive behaviors, 2010-03, Vol.35 (3), p.229-234

2010

Volltextzugriff (PDF)

Feasibility of a novel wrist-worn thermal device for management of vasomotor symptoms in patients with prostate cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5067-5067

2022

Volltextzugriff (PDF)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17604-e17604

2023

Volltextzugriff (PDF)

PMON68 Effect of an Amino-Acid Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A560-A561

2022

Volltextzugriff (PDF)

Peptide YY^sub (3-36)^ Inhibits Morning, but Not Evening, Food Intake and Decreases Body Weight in Rhesus Macaques

Diabetes (New York, N.Y.), 2005-11, Vol.54 (11), p.3198

2005

Volltextzugriff (PDF)

Peptide Y[Y.sub.] inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

Diabetes (New York, N.Y.), 2005-11, Vol.54 (11), p.3198

2005

Volltextzugriff (PDF)

Pharmacologic interventions for weight-related health risks: evidence-based guidelines for obesity support the use of pharmacologic therapy in collaboration with lifestyle interventions

The clinical advisor, 2014-10, Vol.17 (10), p.51

2014

Volltextzugriff (PDF)

Diversity in der LehrerInnenbildung: Internationale Dimensionen der Vielfalt in Forschung und Praxis

2017

Volltextzugriff (PDF)

Schnittstelle Kunst - Vermittlung

2007

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss

Effect of time restricted eating on body weight and fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trial

Stress-associated weight gain, fibromyalgia symptoms, cardiometabolic markers, and human growth hormone suppression respond to an amino acid supplement blend: Results of a prospective, cohort study

Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer

Diet-Induced Obesity Causes Severe but Reversible Leptin Resistance in Arcuate Melanocortin Neurons

Catecholamine Reuptake Inhibition Causes Weight Loss by Increasing Locomotor Activity and Thermogenesis

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer

Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism

Combination therapy with naltrexone and bupropion for obesity

Inhibition of Dopamine and Norepinephrine Reuptake Produces Additive Effects on Energy Balance in Lean and Obese Mice

Peptide YY(3–36) Inhibits Morning, but Not Evening, Food Intake and Decreases Body Weight in Rhesus Macaques

An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects

Feasibility of a novel wrist-worn thermal device for management of vasomotor symptoms in patients with prostate cancer

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer

PMON68 Effect of an Amino-Acid Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms

Peptide YY^sub (3-36)^ Inhibits Morning, but Not Evening, Food Intake and Decreases Body Weight in Rhesus Macaques

Peptide Y[Y.sub.] inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

Pharmacologic interventions for weight-related health risks: evidence-based guidelines for obesity support the use of pharmacologic therapy in collaboration with lifestyle interventions

Diversity in der LehrerInnenbildung: Internationale Dimensionen der Vielfalt in Forschung und Praxis

Schnittstelle Kunst - Vermittlung

Suchergebnisse filtern